We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Advanced Imaging Increases Incidentaloma Findings

By MedImaging International staff writers
Posted on 13 Aug 2018
Print article
Image: Cystic pancreatic incidentaloma in a 75-year-old woman with hematuria (Photo courtesy of NIH).
Image: Cystic pancreatic incidentaloma in a 75-year-old woman with hematuria (Photo courtesy of NIH).
High-resolution magnetic resonance imaging (MRI) and positron emission technology (PET) scans increasingly distinguish incidental abnormalities that once went undetected, claims a new study.

Researchers at the University of Oxford (United Kingdom), Stanford University School of Medicine (CA, USA), and other institutions conducted an umbrella review of systematic reviews and meta-analyses of observational studies that reported prevalence of incidental abnormalities (incidentalomas) up to August 2017. An incidental imaging finding was defined as an imaging abnormality in a healthy, asymptomatic patient or an imaging abnormality in a symptomatic patient, where the abnormality was not apparently related to the patient’s symptoms.

The prevalence of incidentalomas varied substantially between imaging tests; it was less than 5% for chest computed tomography (CT) for incidental pulmonary embolism in patients with and without cancer and for whole body PET or PET/CT, also for patients with and without cancer; in these situations, incidentalomas were often found in blood vessels. Conversely, incidentalomas occurred in more than a third of images in cardiac MRI, chest CT, and CT colonoscopy. Intermediate rates occurred with MRI of the spine (22%) and brain (22%).

The rate of malignancy in incidentalomas varied substantially between organs; prevalence of malignancy was less than one hundredth of one percent in the brain, and less than 5% in incidentalomas of the parotid and adrenal gland. Extra-colonic, prostatic, and colonic incidentalomas were malignant 10-20% of the time, whereas renal, thyroid, and ovarian incidentalomas were malignant 25% of the time. Breast incidentalomas had the highest percentage of malignancy (42%), followed by 28% of incidentalomas in the ovaries and 11% in the prostate. The study was published on June 18, 2018, in The BMJ.

“Computed tomography of the chest, computed tomography colonoscopy, and cardiac MRI imaging scans have the highest frequencies of detecting incidentalomas,” concluded lead author Jack O’Sullivan, MSc, of Oxford University, and colleagues. “This umbrella review will help clinicians and patients weigh up the pros and cons of requesting imaging scans, and will assist with management decisions after an incidentaloma diagnosis. Our results can underpin the creation of guidelines to assist clinicians and patients through these decisions.”

Related Links:
University of Oxford
Stanford University School of Medicine
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Oncology Information System
RayCare
New
Ultrasound System
Acclarix AX9
New
PACS Workstation
CHILI Web Viewer

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.